Mumbai, India
Inneate Hub Private Limited is making significant strides in the pharmaceutical packaging sector with its focus on polymer excellence. Since its founding in 2019, this India-based startup has been dedicated to redefining primary packaging solutions for injectables.
The company distinguishes itself through its cutting-edge, fully automated manufacturing facility, the first of its kind in India. This facility emphasizes advanced contamination control with cleanroom infrastructure, which ensures minimal human contact and maximal sterility, aligning with global standards. Through its expertise in formulation, Inneate can customize rubber and silicon closures that meet diverse drug requirements and compliance mandates, such as US FDA and EU GMP.
While the injectable drug market grows, Inneate aims to provide world-class, locally manufactured components, reducing the sector's dependency on imports. Its strategic position at the intersection of health care, medical devices, and supply chain industries highlights its potential. Investors may note the company's untapped prospects given its last support through a Seed Round investment on 01 June 2019.
